KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Goodwill & Intangibles (2018 - 2025)

Esperion Therapeutics' Goodwill & Intangibles history spans 8 years, with the latest figure at $56000.0 for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles changed 0.0% year-over-year to $56000.0; the TTM value through Dec 2025 reached $56000.0, changed 0.0%, while the annual FY2025 figure was $56000.0, 0.0% changed from the prior year.
  • Goodwill & Intangibles reached $56000.0 in Q4 2025 per ESPR's latest filing, roughly flat from $56000.0 in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $56000.0 in Q1 2021 to a low of $56000.0 in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $56000.0, with a median of $56000.0 recorded in 2021.
  • The largest YoY upside for Goodwill & Intangibles was 0.0% in 2021 against a maximum downside of 0.0% in 2021.
  • A 5-year view of Goodwill & Intangibles shows it stood at $56000.0 in 2021, then changed by 0.0% to $56000.0 in 2022, then changed by 0.0% to $56000.0 in 2023, then changed by 0.0% to $56000.0 in 2024, then changed by 0.0% to $56000.0 in 2025.
  • Per Business Quant, the three most recent readings for ESPR's Goodwill & Intangibles are $56000.0 (Q4 2025), $56000.0 (Q3 2025), and $56000.0 (Q2 2025).